Elizabeth Serra

Education

M.Sc., public health, McGill University; B.S., biology (honours), Bishop’s University

Summary of Experience

Ms. Serra specializes in epidemiology and health economics and outcomes research. She has extensive experience in retrospective database and claims database analyses; patient, physician, and caregiver survey studies; and the assessment of treatment patterns, burden of illness, and real-world safety and effectiveness of treatments. Ms. Serra has conducted research in multiple therapeutic areas, including ophthalmology, dermatology, gastroenterology, and psychiatry. Her research has been presented at conferences such as the International Society for Pharmacoeconomics and Outcomes Research, the Academy of Managed Care Pharmacy, and the American Academy of Dermatology, and published in peer-reviewed journals such as the Journal of Medical Economics, BMC Psychiatry, and the Journal of Managed Care & Specialty Pharmacy.

Read Elizabeth's profile

Selected Publishing

• Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey

  Kidney Medicine, 2022
  2022

  Michalopoulos SN, Gauthier-Loiselle M, Aigbogun MS, Serra E, Bungay R, Clynes D, Cloutier M, Kahle E, Guérin A, Farag YMK, Wish JB

  HEOR, Epidemiology & Market Access
• Identifying Individuals with Undiagnosed Post-Traumatic Stress Disorder in a Large United States Civilian Population – A Machine Learning Approach

  BMC Psychiatry, 2022
  2022

  Gagnon-Sanschagrin P, Schein J, Urganis A, Serra E, Liang Y, Musingarimi P, Cloutier M, Guérin A, Davis L

  Data Science & Statistical Modeling, Health Care, HEOR, Epidemiology & Market Access
• Impact of agitation in long-term care residents with dementia in the United States

  International Journal of Geriatric Psychiatry, 2021
  2021

  Fillit H, Aigbogun MS, Gagnon-Sanschagrin P, Cloutier M, Davidson M, Serra E, Guérin A, Baker RA, Houle CR, Grossberg G

  HEOR, Epidemiology & Market Access
• Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer's perspective

  BMJ Open Opthalmology, 2021
  2021

  Hariprasad SM, Joseph G, Gagnon-Sanschagrin P, Serra E, Bhattacharyya S, Bédard J, Guérin A, Albini TA

  HEOR, Epidemiology & Market Access
• Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective

  Journal of Managed Care & Specialty Pharmacy, 2021
  2021

  Gauthier-Loiselle M, Michalopoulos SN, Cloutier M, Serra E, Bungay R, Szabo E, Guérin A

  HEOR, Epidemiology & Market Access
• Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers

  Journal of Medical Economics, 2020
  2020

  Shah NR, Bhor M, Latremouille-Viau D, Sharma VK, Puckrein GA, Gagnon-Sanschagrin P, Khare A, Singh MK, Serra E, Davidson M, Xu L, Guerin A

  HEOR, Epidemiology & Market Access

News

• October 23, 2023

  HEOR and Epidemiology Research from Analysis Group Featured at AMCP Nexus Meeting

  HEOR, Epidemiology & Market Access